COLL - Company ID 0001267565
The table below shows COLLEGIUM PHARMACEUTICAL, INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $231.25M | $70.56M | $238.95M | $173.69M | $186.43M | $174.12M |
| Short-term investments | $155.43M | $92.20M | $71.60M | - | - | - |
| Receivables | $211.33M | $228.54M | $179.53M | $183.12M | $105.84M | $83.32M |
| Inventory | $40.91M | $35.56M | $32.33M | $46.50M | $17.39M | $15.61M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $691.41M |
| $482.26M |
| $537.60M |
| $419.99M |
| $315.54M |
| $277.89M |
| Property, plant & equipment | $12.01M | $14.33M | $15.98M | $19.52M | $19.49M | $18.99M |
| Goodwill | $145.93M | $162.33M | $133.86M | $133.69M | - | - |
| Total assets | $1.66B | $1.66B | $1.14B | $1.17B | $692.08M | $643.84M |
| Accounts payable | $10.66M | $3.93M | $8.69M | $3.49M | $4.19M | $10.02M |
| Total current liabilities | $440.03M | $509.51M | $457.92M | $433.73M | $279.57M | $239.45M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $1.36B | $1.43B | $947.88M | $979.29M | $489.15M | $457.81M |
| Retained earnings | -$101.13M | -$164.00M | -$233.19M | -$281.34M | -$256.34M | -$333.15M |
| Total equity | $301.68M | $228.84M | $195.43M | $194.84M | $202.93M | $186.03M |